Thromboembolism during immune checkpoint inhibitor therapy: frequency and risk factors
These results suggested that the frequency of TE is higher than expected and should be considered and monitored in patients treated with ICIs.
Authors
- Takayuki Ide (ORCID: https://orcid.org/0009-0002-3094-1445)
- Tomonobu Koizumi (ORCID: https://orcid.org/0000-0002-5182-0960)
- Taisuke Araki (ORCID: https://orcid.org/0000-0002-8033-868X)
Institutions
- Shinshu University (JP)
- Shinshu University Hospital (JP)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1007/s12672-024-01416-z
- Citations
- 7
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.85